Mark Tannenbaum

4.1k total citations · 1 hit paper
28 papers, 1.7k citations indexed

About

Mark Tannenbaum is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Tannenbaum has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Tannenbaum's work include Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Mark Tannenbaum is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Mark Tannenbaum collaborates with scholars based in United States, Australia and Canada. Mark Tannenbaum's co-authors include Valentı́n Fuster, Dimitrios Alexopoulos, Melvin B. Weiss, Susan Borrico, John A. Ambrose, Craig E. Hjemdahl-Monsen, Richard Gorlin, Jeffrey A. Leavy, Eric J. Topol and Alan Niederman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Mark Tannenbaum

27 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiographic progression of coronary artery disease and the development of myocardial infarction

1988 1.0k citations John A. Ambrose, Mark Tannenbaum et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Mark Tannenbaum

Since Specialization

Citations

This map shows the geographic impact of Mark Tannenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tannenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tannenbaum more than expected).

Fields of papers citing papers by Mark Tannenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tannenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tannenbaum. The network helps show where Mark Tannenbaum may publish in the future.

Co-authorship network of co-authors of Mark Tannenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tannenbaum. A scholar is included among the top collaborators of Mark Tannenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tannenbaum. Mark Tannenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STEMI: Considerations for Left Main Culprit Lesions 2022 ·Current Cardiology Reports ·(unknown), Frank V. Aguirre, Jenny Chambers, Scott W. Sharkey, Mark Tannenbaum, (unknown), Ross Garberich, Santiago García, Timothy D. Henry	5
2	Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction 2021 ·The American Journal of Cardiology ·Judit Karácsonyi, Christian Schmidt, (unknown), Santiago García, Timothy D. Henry, Ilias Nikolakopoulos, Evangelia Vemmou, (unknown), Scott W. Sharkey, Frank V. Aguirre, Mark Tannenbaum, M. Nicholas Burke, Mario Goessl, Paul Sorajja, Jay H. Traverse, Yale L. Wang, Emmanouil S. Brilakis	3
3	Coronary artery aneurysm presenting as acute coronary syndrome: two case reports and a review of the literature 2021 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), (unknown), Russell J. Hamilton, Mark Tannenbaum, Magdi Ghali	4
4	Diabetic Patients Who Present With ST-Elevation Myocardial Infarction 2021 ·Cardiovascular revascularization medicine ·Michael Megaly, Christian Schmidt, Marshall Dworak, Ross Garberich, Larissa Stanberry, (unknown), Emmanouil S. Brilakis, Frank V. Aguirre, (unknown), Mark Tannenbaum, (unknown), (unknown), Timothy D. Henry, Santiago García	8
5	Incidence and Long‐Term Outcomes of Stroke in Patients Presenting With ST‐Segment Elevation–Myocardial Infarction: Insights From the Midwest STEMI Consortium 2021 ·Journal of the American Heart Association ·Michael Megaly, Mehmet Yildiz, (unknown), (unknown), Marshall Dworak, Ross Garberich, Scott W. Sharkey, Frank Aguirre, Mark Tannenbaum, (unknown), Timothy D. Henry, Santiago García	3
6	Coronary Artery Fistulae in Adult: Two Decades of Experience in Clinical Presentation, Angiographic Feature, and Management 2021 ·International Journal of Angiology ·(unknown), (unknown), Russell J. Hamilton, (unknown), (unknown), Mark Tannenbaum, Magdi Ghali	2
7	CLINICAL OUTCOMES OF ANTERIOR STEMI PATIENTS ELIGIBLE FOR THE DOOR TO UNLOAD TRIAL 2020 ·Journal of the American College of Cardiology ·Timothy D. Henry, Santiago García, Christian Schmidt, Ross Garberich, Frank V. Aguirre, Mark Tannenbaum, (unknown), Scott W. Sharkey	1
8	The Midwest ST-Elevation Myocardial Infarction Consortium: Design and Rationale 2020 ·Cardiovascular revascularization medicine ·(unknown), Scott W. Sharkey, Frank V. Aguirre, Mark Tannenbaum, Ross Garberich, (unknown), (unknown), Christian Schmidt, (unknown), (unknown), Jenny Chambers, (unknown), Santiago García, Timothy D. Henry	12
9	Are the Results of a Regional ST-Elevation Myocardial Infarction System Reproducible? 2012 ·The American Journal of Cardiology ·(unknown), Sue Duval, Mark Tannenbaum, Susan Brown, Anil Poulose, L.A. Iannone, David M. Larson, Magdi Ghali, Timothy D. Henry	8
10	Impact of Stent Deployment Procedural Factors on Long-Term Effectiveness and Safety of Sirolimus-Eluting Stents (Final Results of the Multicenter Prospective STLLR Trial) 2008 ·The American Journal of Cardiology ·Marco A. Costa, Dominick J. Angiolillo, Mark Tannenbaum, (unknown), Alan Chu, John B. Patterson, W D Kuehl, Joseph Battaglia, (unknown), Fayez Shamoon, (unknown), Alan Niederman, Theodore A. Bass	167
11	Strategies for drug‐eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e‐Cypher S.T.L.L.R.Trial 2008 ·Catheterization and Cardiovascular Interventions ·Nobuaki Suzuki, Dominick J. Angiolillo, Mark Tannenbaum, (unknown), Conrad Smith, Mahesh Bikkina, Clyde R. Meckel, (unknown), (unknown), (unknown), Hiram G. Bezerra, Theodore A. Bass, Marco A. Costa	5
12	Impact of Platelet Glycoprotein IIb/IIIa Inhibition on the Paclitaxel-Eluting Stent in Patients With Stable or Unstable Angina Pectoris or Provocable Myocardial Ischemia (A TAXUS IV Substudy) 2005 ·The American Journal of Cardiology ·Paul S. Teirstein, John Kao, Matthew W. Watkins, Mark Tannenbaum, Nathan Laufer, Michael Chang, Roxana Mehran, George Dangas, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone	9
13	Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) 2004 ·The American Journal of Cardiology ·A. Michael Lincoff, John A. Bittl, Neal S. Kleiman, Ian J. Sarembock, (unknown), Sameer Mehta, Mark Tannenbaum, Alan Niederman, William Bachinsky, (unknown), Hannah Parker, Dean J. Kereiakes, Robert A. Harrington, Frederick Feit, (unknown), Derek P. Chew, Eric J. Topol	164
14	Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience. 2004 ·PubMed ·Warren J. Cantor, James E. Tcheng, James C. Blankenship, J.Conor O’Shea, Karen S. Pieper, Douglas A. Criger, Mina Madan, John Ducas, (unknown), Mark Tannenbaum, Jack E. Smith, Michael M. Kitt, Ian C. Gilchrist	2
15	Organizational Values and Leadership: Learn More about the Importance of Aligning Core and Operational Values in the Strategic Planning Process and the Bottom-Line Benefits of Investing in a Performance-Oriented Organizational Culture 2003 ·Mark Tannenbaum	1
16	Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis 1996 ·Catheterization and Cardiovascular Diagnosis ·L.A. Iannone, Paul Underwood, Amar Nath, Mark Tannenbaum, (unknown), (unknown)	90
17	Sheathless insertion of the percutaneous intraaortic balloon pump: An alternate method 1992 ·The Annals of Thoracic Surgery ·Steven J. Phillips, Mark Tannenbaum, Robert H. Zeff, L.A. Iannone, Magdi Ghali, (unknown)	8
18	Benefits of combined balloon pumping and percutaneous cardiopulmonary bypass 1992 ·The Annals of Thoracic Surgery ·Steven J. Phillips, (unknown), (unknown), A Grignon, Lawrence Barker, L.A. Iannone, Mark Tannenbaum, (unknown), William Wickemeyer, Magdi Ghali, David F. Gordon	16
19	Angiographic progression of coronary artery disease and the development of myocardial infarction breakdown → 1988 ·Journal of the American College of Cardiology ·John A. Ambrose, Mark Tannenbaum, Dimitrios Alexopoulos, Craig E. Hjemdahl-Monsen, Jeffrey A. Leavy, Melvin B. Weiss, Susan Borrico, Richard Gorlin, Valentı́n Fuster	1021
20	45-Year-old wiman develops acute left ventricular ischemia and dysfunction after subxiphoid drainage of a pericardial tamponade 1987 ·Journal of Cardiothoracic Anesthesia ·Steven N. Konstadt, Joel A. Kaplan, Mark Tannenbaum, (unknown), (unknown), Fabrizio Follis	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact